Search

Your search keyword '"Vacca, Michele"' showing total 519 results

Search Constraints

Start Over You searched for: Author "Vacca, Michele" Remove constraint Author: "Vacca, Michele"
519 results on '"Vacca, Michele"'

Search Results

51. Additional file 2 of Transcriptional, epigenetic and metabolic signatures in cardiometabolic syndrome defined by extreme phenotypes

52. Additional file 3 of Transcriptional, epigenetic and metabolic signatures in cardiometabolic syndrome defined by extreme phenotypes

53. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

54. The stem/progenitor landscape is reshaped in a mouse model of essential thrombocythaemia and causes excess megakaryocyte production

55. Early Neutrophilia Marked by Aerobic Glycolysis Sustains Host Metabolism and Delays Cancer Cachexia

56. Reply

57. Loss of function variant in SMIM1 is associated with reduced energy expenditure and weight gain

61. Comparison between peripheral blood progenitor cell collection on the 4th or 5th day of granulocyte colony-stimulating factor treatment in allogeneic stem cell donors: implications for hematopoietic progenitor cell apheresis guidelines.

62. Phenyl-gamma-valerolactones, flavan-3-ol colonic metabolites, protect brown adipocytes from oxidative stress without affecting their differentiation or function

63. Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease

65. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

66. Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression

69. Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling

71. Early neutrophilia marked by aerobic glycolysis sustains host metabolism and delays cancer cachexia

72. Abstract 89: A TGF-beta Pathway-SREBP1 axis controls liver diseases from nonalcoholic steatohepatitis to hepatocellular carcinoma

73. Correction: Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort (vol 12, pg 505, 2020)

75. Su557 β-SPECTRIN (SPTBN1) DEFICIENCY PROTECTS MICE AGAINST HIGH-FAT DIET-INDUCED NONALCOHOLIC STEATOHEPATITIS AND HEPATOCELLULAR CARCINOMA THROUGH THE REGULATION OF SREBP1

76. Corrigendum to: “Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort”☆ (J Hepatol [2020] 505–515)

77. let-7e downregulation characterizes early phase colonic adenoma in APCMin/+ mice and human FAP subjects

79. Extreme phenotypes define epigenetic and metabolic signatures in cardiometabolic syndrome

80. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

81. A report from the SIdEM: Italy

82. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort

83. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

86. Moderate Exercise Inhibits Age-Related Inflammation, Liver Steatosis, Senescence, and Tumorigenesis

92. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

94. Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular Carcinoma

95. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

96. Phospholipid metabolism rewiring in liver regeneration and hepatocellular carcinoma

98. Transcriptional, epigenetic and metabolic signatures in cardiometabolic syndrome defined by extreme phenotypes

99. Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease

100. Leukapheresis cell concentration adjustment required for a successful recovery of HSC after cryopreservation

Catalog

Books, media, physical & digital resources